(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CITOCBC

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

CITOCBC

ST13

US500000098840477

Class

5, 10

Filing

98840477

Registration

8298011

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

25

Latest update

06/09/2026

Trademark type

Word

Nice classes

5, 10

Filing date

11/06/2024

Registration date

06/09/2026

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/09/2026

Last transaction

06/09/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

03/10/2025

First use in commerce

04/24/2025

Drawing code

4

Owner type

03

Owner location

Irvine, CA, US

Examiner

LOVELACE, JAMES B

Law office

N10

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

CytoChip Inc.

Representatives

Wangxue Deng AVEK IP, LLC

Technical classification

Nice Classes

Class 5Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detectionanemiainfections bacterial and viral; Diagnostic kits consisting primarily of monoclonal antibodiesbuffersreagents for use in disease testing; Diagnostic biomarker reagents for medical purposes; Blood componentsblood cellblood plasma; Blood for medical purposes; Medical diagnostic test stripsfor blood analysisurine analysissaliva analysisplatelet-rich plasma analysisbone marrow aspirate analysis; Enzyme preparations for medical purposes; Chemical reagents for medical or veterinary purposes; Diagnostic preparations for medical purposes; Diagnostic agents for medical use; Pharmaceutical preparationsexcluding ophthalmic and otorhinological pharmaceutical preparations for the treatment of platelet-rich plasma injectionbone marrow injection; Veterinary preparations for platelet-rich plasma injectionbone marrow injection; Veterinary test strips for blood analysisurine analysissaliva analysisplatelet-rich plasma analysisbone marrow aspirate analysis; Diagnostic preparations for veterinary use

Class 10

Cytometers for medical diagnostic use; Diagnostic kits consisting primarily of probesbuffers and reagents for use in microbial testing; Flow cytometers and flow-based analyzers providing cell and particle analysisdetectioncounting for medicalclinicalmedical diagnostictherapeutic uses; Flow cytometers for medical diagnostic uses; Hematology analyzers for medical diagnostic uses; Medical apparatus and instrument for diagnostic useapparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testingcytology and cell-based testing; Medical diagnostic instruments for the analysis of body fluids; Apparatus for blood analysis; Surgical apparatus and instruments; Blood testing equipment; Medical apparatus and devicescell counter for whole bloodplasma and bone marrow aspirate; Medical equipment boxcases fitted for medical instrumentssold empty; Veterinary apparatus and instrumentscell counter for whole bloodplasma and bone marrow aspirate for veterinary use; Medical analysis instrumentscell counter for whole bloodplasmabone marrow aspirate and other body fluids; Medical diagnostic instrumentshematology analyzer and differential cell counter.

Publications

History of USPTO decisions and trademark events.

25 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

06/09/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

06/09/2026

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

05/21/2026

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

05/21/2026

SUPC

STATEMENT OF USE PROCESSING COMPLETE

04/28/2026

IUAF

USE AMENDMENT FILED

12/10/2025

EISU

TEAS STATEMENT OF USE RECEIVED

12/10/2025

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

08/26/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

07/01/2025

PUBO

PUBLISHED FOR OPPOSITION

07/01/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

06/25/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/29/2025

XAEC

EXAMINER'S AMENDMENT ENTERED

05/29/2025

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

05/29/2025

GNEA

EXAMINERS AMENDMENT E-MAILED

05/29/2025

CNEA

EXAMINERS AMENDMENT -WRITTEN

05/29/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/28/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/28/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/28/2025

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

05/07/2025

GNRT

NON-FINAL ACTION E-MAILED

05/07/2025

CNRT

NON-FINAL ACTION WRITTEN

05/07/2025

DOCK

ASSIGNED TO EXAMINER

05/05/2025

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/26/2025

NWAP

NEW APPLICATION ENTERED

11/06/2024

Continuous trademark protection

Get notified about every new filing that threatens CITOCBC or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.